These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The impact of motor symptoms on self-reported anxiety in Parkinson's disease. Salazar RD; Le AM; Neargarder S; Cronin-Golomb A Parkinsonism Relat Disord; 2017 May; 38():26-30. PubMed ID: 28256435 [TBL] [Abstract][Full Text] [Related]
3. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Shulman LM; Taback RL; Rabinstein AA; Weiner WJ Parkinsonism Relat Disord; 2002 Jan; 8(3):193-7. PubMed ID: 12039431 [TBL] [Abstract][Full Text] [Related]
4. Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study. Rutten S; van der Ven PM; Weintraub D; Pontone GM; Leentjens AFG; Berendse HW; van der Werf YD; van den Heuvel OA Parkinsonism Relat Disord; 2017 Oct; 43():49-55. PubMed ID: 28711192 [TBL] [Abstract][Full Text] [Related]
6. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation. Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781 [TBL] [Abstract][Full Text] [Related]
7. The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease. Rutten S; Vriend C; van der Werf YD; Berendse HW; Weintraub D; van den Heuvel OA Parkinsonism Relat Disord; 2017 Jun; 39():31-36. PubMed ID: 28365203 [TBL] [Abstract][Full Text] [Related]
8. Impact of sleep quality on the quality of life of patients with Parkinson's disease: a questionnaire based study. Pandey S; Bajaj BK; Wadhwa A; Anand KS Clin Neurol Neurosurg; 2016 Sep; 148():29-34. PubMed ID: 27372436 [TBL] [Abstract][Full Text] [Related]
9. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study. Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343 [TBL] [Abstract][Full Text] [Related]
10. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study. Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL; CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687 [TBL] [Abstract][Full Text] [Related]
13. The Associations Between Physical Activity, Sleep, and Mood with Pain in People with Parkinson's Disease: An Observational Cross-Sectional Study. Nguy V; Barry BK; Moloney N; Hassett LM; Canning CG; Lewis SJG; Allen NE J Parkinsons Dis; 2020; 10(3):1161-1170. PubMed ID: 32333551 [TBL] [Abstract][Full Text] [Related]
14. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O; Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403 [TBL] [Abstract][Full Text] [Related]
15. Comorbidity of the nonmotor symptoms of Parkinson's disease. Shulman LM; Taback RL; Bean J; Weiner WJ Mov Disord; 2001 May; 16(3):507-10. PubMed ID: 11391746 [TBL] [Abstract][Full Text] [Related]
16. Development of anxiety in early Parkinson's disease: A clinical and biomarker study. Wang H; Zhao Y; Schrag A Eur J Neurol; 2023 Sep; 30(9):2661-2668. PubMed ID: 37227928 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Duodopa Ciurleo R; Corallo F; Bonanno L; Lo Buono V; Di Lorenzo G; Versaci R; Allone C; Palmeri R; Bramanti P; Marino S J Neurol; 2018 Sep; 265(9):2005-2014. PubMed ID: 29951701 [TBL] [Abstract][Full Text] [Related]
18. Sleep disturbances in Taiwanese patients with Parkinson's disease. Lin YY; Chen RS; Lu CS; Huang YZ; Weng YH; Yeh TH; Lin WY; Hung J Brain Behav; 2017 Oct; 7(10):e00806. PubMed ID: 29075566 [TBL] [Abstract][Full Text] [Related]
19. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study. Happe S; Berger K; J Neurol; 2001 Dec; 248(12):1062-7. PubMed ID: 12013583 [TBL] [Abstract][Full Text] [Related]
20. Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease. Kaminska M; Mery VP; Lafontaine AL; Robinson A; Benedetti A; Gros P; Kimoff RJ J Clin Sleep Med; 2018 May; 14(5):819-828. PubMed ID: 29734988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]